Published in J Pharmacol Exp Ther on April 01, 1981
Periportal- and perivenous-enriched hepatocyte couplets: differences in canalicular activity and in response to oxidative stress. Biochem J (1993) 0.83
Fluorescence-microscopic measurement of intracellular cytochrome P-450 enzyme activity (ethoxyresorufin O-de-ethylation) in unfixed liver section. Biochem J (1983) 0.78
A Cytochrome P450-Independent Mechanism of Acetaminophen-Induced Injury in Cultured Mouse Hepatocytes. J Pharmacol Exp Ther (2015) 0.78
Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies. Curr Pathobiol Rep (2014) 0.76
Incidence of uraemia and requirements for maintenance haemodialysis. Br Med J (1971) 7.17
Analysis of 1.9 Mb of contiguous sequence from chromosome 4 of Arabidopsis thaliana. Nature (1998) 5.91
The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest (1975) 4.65
Molecular recombination in T4 bacteriophage deoxyribonucleic acid. I. Tertiary structure of early replicative and recombining deoxyribonucleic acid. J Virol (1967) 3.96
Homeosis and intestinal tumours in Cdx2 mutant mice. Nature (1997) 3.68
Inhibition of an early event in the cell division cycle of Escherichia coli by FL1060, an amidinopenicillanic acid. J Bacteriol (1975) 3.49
Structural and mechanistic basis of immunity toward endonuclease colicins. Nat Struct Biol (1999) 3.37
Polypeptide growth factors. Annu Rev Biochem (1984) 2.88
A magnetic resonance imaging study of white matter lesions in depression and Alzheimer's disease. Br J Psychiatry (1996) 2.75
Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations. Clin Pharmacol Ther (1985) 2.69
Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man. Eur J Clin Pharmacol (1984) 2.66
Lipid- and temperature-dependent structural changes in Acholeplasma laidlawii cell membranes. Biochim Biophys Acta (1973) 2.59
Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation. Clin Pharmacol Ther (1985) 2.50
Expression of Cdx-2 in the mouse embryo and placenta: possible role in patterning of the extra-embryonic membranes. Dev Dyn (1995) 2.43
The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42
General hospital services for attempted suicide patients: a survey in one region. Health Trends (1995) 2.38
The accuracy of EUS-FNA in assessing mediastinal lymphadenopathy and staging patients with NSCLC. Eur Respir J (2005) 2.37
Pharmacokinetics and organ distribution of intravenous and oral methylene blue. Eur J Clin Pharmacol (2000) 2.24
Determinants of serum antipyrine half-lives in patients with liver disease. Gut (1973) 2.19
Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism. Clin Pharmacol Ther (1984) 2.19
Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study. Arch Gen Psychiatry (1999) 2.14
Safety of surfaces and equipment for children in playgrounds. Lancet (1997) 2.12
False positives with current carbocisteine protocol for sulphoxidation phenotyping. Lancet (1990) 2.05
Assortative interactions and social networks in fish. Oecologia (2005) 1.97
Rapid folding with and without populated intermediates in the homologous four-helix proteins Im7 and Im9. J Mol Biol (1999) 1.97
Clinical evaluation of fibreoptic sigmoidoscopy employing the Olympus CF-SB colonoscope. Gut (1971) 1.90
Integrated regional haemodialysis and renal transplantation centre. Br Med J (1970) 1.89
Food intolerance and the irritable bowel syndrome. Gut (1989) 1.88
The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man. Br J Clin Pharmacol (1976) 1.88
A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol. Br J Clin Pharmacol (1976) 1.87
Protein-protein interactions in colicin E9 DNase-immunity protein complexes. 1. Diffusion-controlled association and femtomolar binding for the cognate complex. Biochemistry (1995) 1.85
Immunological study of carcinoembryonic antigen (CEA) and a related glycoprotein. Br J Cancer (1973) 1.78
Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow. J Clin Invest (1974) 1.74
Amphotericin B nephrotoxicity. Drug Saf (1990) 1.74
ART adherence, demographic variables and CD4 outcome among HIV-positive patients on antiretroviral therapy in Chennai, India. AIDS Care (2005) 1.73
Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up study. BMJ (1998) 1.73
Normal disposition of oxazepam in acute viral hepatitis and cirrhosis. Ann Intern Med (1976) 1.68
Electrospun nanofiber scaffolds: engineering soft tissues. Biomed Mater (2008) 1.68
Specificity in protein-protein interactions: the structural basis for dual recognition in endonuclease colicin-immunity protein complexes. J Mol Biol (2000) 1.64
Effects of age and cigarette smoking on propranolol disposition. Clin Pharmacol Ther (1979) 1.62
Cimetidine impairs elimination of chlordiazepoxide (Librium) in man. Ann Intern Med (1980) 1.61
Plasma protein map: an update by microsequencing. Electrophoresis (1993) 1.60
Evidence of the involvement of an outer membrane protein in DNA initiation. J Biol Chem (1976) 1.57
Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I). Br J Cancer (2010) 1.57
Prevalence of malnutrition on admission to four hospitals in England. The Malnutrition Prevalence Group. Clin Nutr (2000) 1.56
The North Coast Cholesterol Check Campaign. Results of the first three years of a large-scale public screening programme. Med J Aust (1991) 1.56
Genetic polymorphism of S-mephenytoin hydroxylation. Pharmacol Ther (1989) 1.55
Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination. Clin Pharmacol Ther (1979) 1.55
Acute hepatic necrosis with stupor or coma. An analysis of thirty-one patients. Medicine (Baltimore) (1969) 1.55
White and gray matter alterations in adults with Niemann-Pick disease type C: a cross-sectional study. Neurology (2010) 1.55
Determinants of response to frusemide in normal subjects. Br J Clin Pharmacol (1977) 1.54
Amylase--its clinical significance: a review of the literature. Medicine (Baltimore) (1976) 1.51
Fish shoal composition: mechanisms and constraints. Proc Biol Sci (2000) 1.50
The liver in congestive heart failure: a review. Am J Med Sci (1973) 1.50
Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (librium). Gastroenterology (1978) 1.48
Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial. Blood (1992) 1.45
Structural parsimony in endonuclease active sites: should the number of homing endonuclease families be redefined? FEBS Lett (1999) 1.45
Clinical implications of prostaglandin and thromboxane A2 formation (1). N Engl J Med (1988) 1.45
Acyclovir transport by the human placenta. J Lab Clin Med (1992) 1.42
Impaired elimination of caffeine by oral contraceptive steroids. J Lab Clin Med (1980) 1.41
Neuromuscular dysfunction following eccentric exercise. Med Sci Sports Exerc (1995) 1.41
Efficacy of the FEF colorimetric end-tidal carbon dioxide detector in children. Anesth Analg (1992) 1.40
Effects of aging and liver disease on disposition of lorazepam. Clin Pharmacol Ther (1978) 1.39
Identification of an outer membrane protein of Escherichia coli, with a role in the coordination of deoxyribonucleic acid replication and cell elongation. J Bacteriol (1975) 1.38
Phenotypic differences in mephenytoin pharmacokinetics in normal subjects. J Pharmacol Exp Ther (1985) 1.38
Translationally controlled tumor protein: a protein identified in several nontumoral cells including erythrocytes. Electrophoresis (1997) 1.36
Turner syndrome: a cytogenetic and molecular study. Ann Hum Genet (1997) 1.36
Preventing injuries in public playgrounds through partnership between health services and local authority: community intervention study. BMJ (1999) 1.36
Mechanism and cleavage specificity of the H-N-H endonuclease colicin E9. J Mol Biol (2001) 1.36
Biological determinants of propranolol disposition in man. Clin Pharmacol Ther (1978) 1.35
Aminopyrine demethylation measured by breath analysis in cirrhosis. Clin Pharmacol Ther (1976) 1.35
Carcinoembryonic antigen in the urine of patients with urothelial carcinoma. Br Med J (1972) 1.34
Identification of putative active-site residues in the DNase domain of colicin E9 by random mutagenesis. J Mol Biol (1996) 1.33
Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes. Clin Pharmacol Ther (1997) 1.33
Cimetidine spares the glucuronidation of lorazepam and oxazepam. Gastroenterology (1980) 1.33
Fatty liver: biochemical and clinical considerations. Am J Dig Dis (1975) 1.30
Personality in the context of social networks. Philos Trans R Soc Lond B Biol Sci (2010) 1.29
Homing in on the role of transition metals in the HNH motif of colicin endonucleases. J Biol Chem (1999) 1.28
The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration. Clin Pharmacokinet (1979) 1.28
Studies on the intracerebral toxicity of ammonia. J Clin Invest (1967) 1.27
Neuropsychological and structural brain changes in anorexia nervosa before and after refeeding. Psychol Med (1996) 1.27
Pathogenesis of hepatic encephalopathy--with special reference to the role of ammonia. Am J Clin Nutr (1970) 1.27
Inhibition of microsomal drug metabolism by histamine H2-receptor antagonists studied in vivo and in vitro in rodents. Gastroenterology (1982) 1.27
Dextromethorphan as a safe probe for debrisoquine hydroxylation polymorphism. Lancet (1984) 1.26
Characterization and inhibition of mephenytoin 4-hydroxylase activity in human liver microsomes. J Pharmacol Exp Ther (1987) 1.25
Cloning and characterization of the ColE7 plasmid. J Gen Microbiol (1991) 1.25
Mephenytoin hydroxylation deficiency: kinetics after repeated doses. Clin Pharmacol Ther (1984) 1.25
A randomized, placebo-controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen-positive hepatitis B. Hepatology (2000) 1.23
Propranolol disposition in chronic liver disease: a physiological approach. Clin Pharmacokinet (1976) 1.23
The theory of planned behaviour and healthy eating: Examining additive and moderating effects of social influence variables. Psychol Health (2000) 1.22
Specificity in protein-protein recognition: conserved Im9 residues are the major determinants of stability in the colicin E9 DNase-Im9 complex. Biochemistry (1998) 1.22
Teaching clinical pharmacology and therapeutics: selective for fourth-year medical students. J Clin Pharmacol (1998) 1.22
Normal metabolism of morphine in cirrhosis. Gastroenterology (1981) 1.22
The effect of cirrhosis on the disposition and elimination of meperidine in man. Clin Pharmacol Ther (1974) 1.22